Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

PLEKHG1 Activators

The chemical class denoted as PLEKHG1 Activators encompasses a range of compounds that can modulate cellular pathways, ultimately influencing the activity of PLEKHG1. This group of chemicals is not homogenous but rather a collection of diverse molecules that share the common potential to affect signaling cascades and cellular processes linked to PLEKHG1 function. The activators operate through various mechanisms, such as mimicking endogenous molecules, inhibiting regulatory enzymes, or altering the availability of secondary messengers. For instance, some activators within this class can mimic the structure and function of phosphatidylinositol (3,4,5)-trisphosphate (PIP3), thereby recruiting PLEKHG1 to the plasma membrane, which is a prerequisite for its activation. Others, such as LY294002, manipulate the PI3K-AKT pathway turnover, which could transiently enhance PLEKHG1 activity due to fluctuations in downstream signaling molecules.

Furthermore, this chemical class includes activators like cell-permeable C3 Transferase and CN03, which directly influence Rho family GTPase activities, a group of signaling molecules implicated in the regulation of the actin cytoskeleton, where PLEKHG1 is also thought to operate. By modulating these GTPases, the chemicals can alter cytoskeletal dynamics, creating a cellular environment conducive to PLEKHG1 activation. Additional members of this chemical class, such as Y-27632 and ML141, exert their effects by inhibiting kinases and GTPases, respectively, leading to a cascade of events that may stimulate PLEKHG1 activity. These activators target diverse aspects of cellular signaling, including adenylate cyclase activity with compounds like Forskolin, which raises cAMP levels, or ionomycin, which affects calcium signaling.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that increases the turnover of PI3K signaling, possibly leading to transient activation of downstream effectors like PLEKHG1.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

A ROCK inhibitor, which might increase cellular levels of GTP-bound Rac1 and Cdc42, potentially modulating PLEKHG1 activity.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

An activator of adenylate cyclase, increasing cAMP levels, which may indirectly influence signaling pathways associated with PLEKHG1.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

A calcium ionophore that can raise intracellular calcium levels, possibly affecting calcium-dependent pathways related to PLEKHG1 activity.

Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt

94825-44-2sc-202639
10 mg
$465.00
(0)

A non-hydrolyzable analog of GTP that can activate GTPases, potentially modulating the activity of proteins like PLEKHG1 that interact with GTPases.

Jasplakinolide

102396-24-7sc-202191
sc-202191A
50 µg
100 µg
$184.00
$305.00
59
(1)

A stabilizer of F-actin that can modulate actin dynamics, potentially affecting PLEKHG1's role in cytoskeletal reorganization.